Entheon Biomedical Corp Stock Price To Sales
ENTBF Stock | USD 0.17 0.06 26.09% |
Entheon Biomedical Corp fundamentals help investors to digest information that contributes to Entheon Biomedical's financial success or failures. It also enables traders to predict the movement of Entheon OTC Stock. The fundamental analysis module provides a way to measure Entheon Biomedical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Entheon Biomedical otc stock.
Entheon |
Entheon Biomedical Corp OTC Stock Price To Sales Analysis
Entheon Biomedical's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Entheon Biomedical Price To Sales | 9.60 X |
Most of Entheon Biomedical's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Entheon Biomedical Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Competition |
Based on the latest financial disclosure, Entheon Biomedical Corp has a Price To Sales of 9.5966 times. This is 55.16% lower than that of the Healthcare sector and 90.25% lower than that of the Biotechnology industry. The price to sales for all United States stocks is 15.97% higher than that of the company.
Entheon Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Entheon Biomedical's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Entheon Biomedical could also be used in its relative valuation, which is a method of valuing Entheon Biomedical by comparing valuation metrics of similar companies.Entheon Biomedical is currently under evaluation in price to sales category among its peers.
Entheon Fundamentals
Return On Equity | -0.55 | |||
Return On Asset | -0.46 | |||
Operating Margin | (60.27) % | |||
Current Valuation | 1.12 M | |||
Shares Outstanding | 59.09 M | |||
Shares Owned By Insiders | 8.63 % | |||
Price To Book | 0.22 X | |||
Price To Sales | 9.60 X | |||
Revenue | 21.67 K | |||
Gross Profit | 9.13 K | |||
EBITDA | (8.62 M) | |||
Net Income | (8.89 M) | |||
Cash And Equivalents | 467.58 K | |||
Cash Per Share | 0.01 X | |||
Total Debt | 300 K | |||
Debt To Equity | 0.05 % | |||
Current Ratio | 0.97 X | |||
Book Value Per Share | 0.11 X | |||
Cash Flow From Operations | (5.62 M) | |||
Earnings Per Share | (0.11) X | |||
Beta | 1.89 | |||
Market Capitalization | 1.3 M | |||
Total Asset | 9.98 M | |||
Z Score | 2.4 | |||
Net Asset | 9.98 M |
About Entheon Biomedical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Entheon Biomedical Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Entheon Biomedical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Entheon Biomedical Corp based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Entheon OTC Stock
Entheon Biomedical financial ratios help investors to determine whether Entheon OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Entheon with respect to the benefits of owning Entheon Biomedical security.